Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis-Reference-Cited by-同舟云学术

Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis

Published:2020-06-01 Issue:6 Volume:14 Page:e0008301
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Burgert-Brucker Clara R.^ORCID,Zoerhoff Kathryn L.,Headland Maureen,Shoemaker Erica A.,Stelmach Rachel,Karim Mohammad Jahirul^ORCID,Batcho Wilfrid,Bougouma Clarisse,Bougma Roland,Benjamin Didier Biholong,Georges Nko'Ayissi,Marfo Benjamin,Lemoine Jean Frantz,Pangaribuan Helena Ullyartha^ORCID,Wijayanti Eksi,Coulibaly Yaya Ibrahim,Doumbia Salif Seriba,Rimal Pradip,Salissou Adamou Bacthiri,Bah Yukaba,Mwingira Upendo,Nshala Andreas,Muheki Edridah,Shott Joseph,Yevstigneyeva Violetta,Ndayishimye Egide,Baker Margaret,Kraemer John,Brady Molly

Funder

United States Agency for International Development

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference53 articles.

1. World Health Organization. Lymphatic filariasis: progress report 2000–2009 and strategic plan 2010–2020. Geneva; 2010.

2. World Health Organization. Validation of elimination of lymphatic filariasis as a public health problem. Geneva; 2017.

3. Global programme to eliminate lymphatic filariasis: progress report, 2018;World Health Organization;Wkly Epidemiol Rec,2019

4. World Health Organization. Global programme to eliminate lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration. Geneva; 2011.

5. World Health Organization. Strengthening the assessment of lymphatic filariasis transmission and documenting the achievement of elimination—Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators. 2016; 42.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinguishing recrudescence from reinfection in lymphatic filariasis;eBioMedicine;2024-07

2. Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti;Clinical Infectious Diseases;2024-04-25

3. Surveillance and Selective Treatment of Brugia malayi Filariasis Eleven Years after Stopping Mass Drug Administration in Belitung District, Indonesia;The American Journal of Tropical Medicine and Hygiene;2024-01-03

4. Distinguishing recrudescence from reinfection in lymphatic filariasis: a genomics-based approach for monitoring worm burden;2023-11-08

5. How correlations between treatment access and surveillance inclusion impact neglected tropical disease monitoring and evaluation—A simulated study;PLOS Neglected Tropical Diseases;2023-09-06